The intensification of anticancer activity of LFM-A13 by erythropoietin as a possible option for inhibition of breast cancer.
Rozkiewicz D, Hermanowicz JM, Tankiewicz-Kwedlo A, Sieklucka B, Pawlak K, Czarnomysy R, Bielawski K, Surazynski A, Kalafut J, Przybyszewska A, Koda M, Jakubowska K, Rivero-Muller A, Pawlak D.
Rozkiewicz D, et al. Among authors: czarnomysy r.
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1697-1711. doi: 10.1080/14756366.2020.1818738.
J Enzyme Inhib Med Chem. 2020.
PMID: 32912025
Free PMC article.